Antibiotics have revolutionized medicine, but their misuse has led to a global rise in drug-resistant infections, with Staphylococcus aureus at the forefront. Our latest review dives deep into:
- Understanding antibiotic targets and resistance mechanisms.
- Exploring recently approved S. aureus antibiotics.
- Uncovering the promising pre-clinical pipeline of antimicrobials.
We’ll unveil the molecular actions of novel antibiotics, track resistance emergence, and share insights from clinical trials. Together, we’re working towards sustainable solutions against multidrug-resistant S. aureus.
